Login / Signup

Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2.

Nèle F LendersTanya J ThompsonJeanie ChuiJulia LowWarrick J InderPeter E EarlsAnn I McCormack
Published in: Pituitary (2024)
Our study is the first to biologically characterise pituitary tumours WDLD. We demonstrate that these tumours exhibit a higher expression of the stem cell marker SOX2 compared with other lineage-differentiated tumours, suggesting possible involvement of stem cells in their development.
Keyphrases
  • stem cells
  • cell therapy
  • poor prognosis
  • single cell
  • transcription factor
  • growth hormone
  • binding protein
  • long non coding rna